{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:27:49Z","timestamp":1748528869755},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T00:00:00Z","timestamp":1225238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00108-008-2233-6","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T07:49:20Z","timestamp":1225180160000},"page":"1516-1523","source":"Crossref","is-referenced-by-count":4,"title":["Geschlechterunterschiede in der neuropsychiatrischen Pharmakotherapie"],"prefix":"10.1007","volume":"49","author":[{"given":"V.","family":"Regitz-Zagrosek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,29]]},"reference":[{"key":"2233_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00115-006-2112-0","volume":"78","author":"Aichhorn","year":"2007","unstructured":"Aichhorn W, Whitworth AB, Weiss EM et al. (2007) Differences between men and women in side efffects of second generation antipsychotics. Nervenarzt 78: 45\u201352","journal-title":"Nervenarzt"},{"key":"2233_CR2","unstructured":"Altshuler LL, Hendrick V, Cohen LS (1989) Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 59 (Suppl 2) 29\u201333"},{"key":"2233_CR3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/pds.1607","volume":"17","author":"Astr\u00f6m-Lilja","year":"2008","unstructured":"Astr\u00f6m-Lilja C, Odeberg JM, Ekman E, H\u00e4gg S (2008) Drug-induced torsades de pointes: a review of the swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf 17: 587\u2013592","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2233_CR4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jama.1994.03520220016014","volume":"272","author":"Bromiker","year":"1994","unstructured":"Bromiker R, Kaplan M (1994) Apparent intrauterine fetal withdrawal from clomipramine Hydrochloride. JAMA 272: 1722\u20131723","journal-title":"JAMA"},{"key":"2233_CR5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","volume":"271","author":"Cohen","year":"1994","unstructured":"Cohen LS, Friedman JM, Jefferson JW et al. (1994) A reevaluation of risk of utero exposure to lithium. JAMA 271: 146\u2013150","journal-title":"JAMA"},{"key":"2233_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0033-3182(90)72150-0","volume":"31","author":"Cohen","year":"1990","unstructured":"Cohen LS, Heller VL (1990) On the use of anticonvulsants for manic depression during pregnancy. Psychosomatics 31: 462\u2013464","journal-title":"Psychosomatics"},{"key":"2233_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0033-3182(89)72314-8","volume":"30","author":"Cohen","year":"1989","unstructured":"Cohen LS, Heller VL, Rosenbaum JF (1989) Treatment guidelines for psychotropic drug use in pregnancy. Psychosomatics 30: 25\u201333","journal-title":"Psychosomatics"},{"key":"2233_CR8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1176\/ajp.145.6.772-b","volume":"159","author":"Cohen","year":"1988","unstructured":"Cohen LS, Rosenbaum JF, Heller VL (1988) Prescribing lithium for pregnant women. Am J Psychiatry 159: 772\u2013773","journal-title":"Am J Psychiatry"},{"key":"2233_CR9","first-page":"143","volume":"36","author":"Compton","year":"2002","unstructured":"Compton MT, Miller AH (2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 36: 143\u2013164","journal-title":"Psychopharmacol Bull"},{"key":"2233_CR10","first-page":"1026","volume":"43","author":"Flores","year":"2003","unstructured":"Flores PJ, Juarez OH, Flores PC (2003) Effect of menstrual cycle on the pharmacokinetics of ranitidine in healthy volunteers. J Clin Pharmacol 43: 1026","journal-title":"J Clin Pharmacol"},{"key":"2233_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0006-3223(02)01467-1","volume":"52","author":"Frank","year":"2002","unstructured":"Frank E, Rush AJ, Blehar M et al. (2002) Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders. Biol Psychiatry 52: 631\u2013654","journal-title":"Biol Psychiatry"},{"key":"2233_CR12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1528-1157.2001.28899.x","volume":"42","author":"Genton","year":"2001","unstructured":"Genton P, Bauer J, Duncan S et al. (2001) On the association between valproate and polycystic ovary syndrome. Epilepsia 42: 295\u2013304","journal-title":"Epilepsia"},{"key":"2233_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-200302000-00007","volume":"25","author":"Gex-Fabry","year":"2003","unstructured":"Gex-Fabry M, Balant-Gorgia AE, Balant LP (2003) Therapeutic drug monitoring of olanzapine the combined effect of age, gender, smoking, and comedication. Ther Drug Monit 25: 46\u201353","journal-title":"Ther Drug Monit"},{"key":"2233_CR14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.3.10.1381","volume":"3","author":"Goodnick","year":"2002","unstructured":"Goodnick PJ, Rodriguez L, Santana O (2002) Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 3: 1381\u20131391","journal-title":"Expert Opin Pharmacother"},{"key":"2233_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10401230701653294","volume":"19","author":"Grigoriadis","year":"2007","unstructured":"Grigoriadis S, Robinson GE (2007) Gender issues in depression. Ann Clin Psychiatry 19: 247\u2013255","journal-title":"Ann Clin Psychiatry"},{"key":"2233_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-3223(98)00125-5","volume":"45","author":"Grunder","year":"1999","unstructured":"Grunder G, Wetzel H, Schlosser R (1999) Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 45: 89\u201397","journal-title":"Biol Psychiatry"},{"key":"2233_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1099-1263(199801\/02)18:1<15::AID-JAT463>3.0.CO;2-4","volume":"18","author":"Haddad","year":"1998","unstructured":"Haddad L, Milke P, Zapata L (1998) Effect of the menstrual cycle in ethanol pharmacokinetics. J Appl Toxicol 18: 15\u201318","journal-title":"J Appl Toxicol"},{"key":"2233_CR18","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","volume":"64","author":"Haddad","year":"2004","unstructured":"Haddad PM, Wieck A (2004) Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64: 2291\u20132314","journal-title":"Drugs"},{"key":"2233_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0920-9964(01)00256-0","volume":"55","author":"Homel","year":"2002","unstructured":"Homel P, Casey D, Allison DB (2002) Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res 55: 277\u2013284","journal-title":"Schizophr Res"},{"key":"2233_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1185\/030079903125002865","volume":"20","author":"Hummer","year":"2004","unstructured":"Hummer M, Huber J (2004) Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin 20: 189\u2013197","journal-title":"Curr Med Res Opin"},{"key":"2233_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1176\/appi.ajp.162.1.162","volume":"162","author":"Hummer","year":"2005","unstructured":"Hummer M, Malik P, Gasser RW (2005) Osteoporosis in patients with schizophrenia. Am J Psychiatry 162: 162\u2013167","journal-title":"Am J Psychiatry"},{"key":"2233_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002280050654","volume":"55","author":"Kamimori","year":"1999","unstructured":"Kamimori GH, Joubert A, Otterstetter R (1999) The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females. Eur J Clin Pharmacol 55: 445\u2013449","journal-title":"Eur J Clin Pharmacol"},{"key":"2233_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199834030-00003","volume":"34","author":"Kasthuba","year":"1998","unstructured":"Kasthuba ADM, Nafziger AN (1998) Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet 34: 203\u2013218","journal-title":"Clin Pharmacokinet"},{"key":"2233_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4088\/JCP.v61n0406","volume":"61","author":"Kennedy","year":"2000","unstructured":"Kennedy SH, Eisfeld BS, Dickens SE et al. (2000) Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 61: 276\u2212281","journal-title":"J Clin Psychiatry"},{"key":"2233_CR25","doi-asserted-by":"crossref","unstructured":"Khan A, Brodhead AE, Schwarzt KA et al. Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 24: 318\u2013324","DOI":"10.1097\/01.jcp.0000168879.03169.ce"},{"key":"2233_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4088\/JCP.v60n0409","volume":"60","author":"Kleiner","year":"1999","unstructured":"Kleiner J, Altshuler L, Hendrick V, Hershman JM (1999) Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 60: 249\u2013255","journal-title":"J Clin Psychiatry"},{"key":"2233_CR27","first-page":"419","volume":"25","author":"Kopecek","year":"2004","unstructured":"Kopecek M, Bares M, Svarc J (2004) Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett 25: 419\u2013422","journal-title":"Neuro Endocrinol Lett"},{"key":"2233_CR28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","volume":"279","author":"Kulin","year":"1998","unstructured":"Kulin NA, Pastuszak A, Sage SR et al. (1998) Pregnancy outcome following maternal use of the new selective serotonin Reuptake inhibitors: a prospective controlled multicenter study. JAMA 279: 609\u2013610","journal-title":"JAMA"},{"key":"2233_CR29","first-page":"2081","volume":"44","author":"Kulin","year":"1998","unstructured":"Kulin NA, Rastuszak A, Koren G (1998) Are the new SSRIs safe for pregnant women? Can Fam Physician 44: 2081\u20132083","journal-title":"Can Fam Physician"},{"key":"2233_CR30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.1992.01820100013002","volume":"49","author":"Kupfer","year":"1992","unstructured":"Kupfer DJ, Frank E, Perel JM et al. (1992) Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49: 769\u2013773","journal-title":"Arch Gen Psychiatry"},{"key":"2233_CR31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9378(80)90864-9","volume":"136","author":"Laukaran","year":"1980","unstructured":"Laukaran VH, van den Berg BJ (1980) The relationship of maternal attitude to pregnancy outcomes and obstetric complications. A cohort study of unwanted pregnancy. Am J Obstet Gynecol 136: 374\u2013379","journal-title":"Am J Obstet Gynecol"},{"key":"2233_CR32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4088\/JCP.v65n1108","volume":"65","author":"Montgomery","year":"2004","unstructured":"Montgomery J, Winterbottom E, Jessani M (2004) Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J Clin Psychiatry 65: 1491\u20131498","journal-title":"J Clin Psychiatry"},{"key":"2233_CR33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","volume":"25","author":"O","year":"2005","unstructured":"O\u2019Keane V, Meaney AM (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J Clin Psychopharmacol 25: 26\u201331","journal-title":"J Clin Psychopharmacol"},{"key":"2233_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00023210-200115070-00004","volume":"15","author":"Russell","year":"2001","unstructured":"Russell JM, Mackell JA (2001) Bodyweight again associated with atypical antipsychotics: epidemiology and therapeutic implications. CNS Drugs 15: 537\u2013551","journal-title":"CNS Drugs"},{"key":"2233_CR35","first-page":"479","volume":"29","author":"Schimmell","year":"1991","unstructured":"Schimmell MS, Katz EZ, Shaag Y et al. (1991) Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toicol 29: 479\u2013484","journal-title":"J Toxicol Clin Toicol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2233-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2233-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2233-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:10Z","timestamp":1558584730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2233-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,29]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2233-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,29]]}}}